Filing Details

Accession Number:
0001368148-21-000122
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-17 11:16:16
Reporting Period:
2021-11-17
Accepted Time:
2021-11-17 11:16:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1368148 Athersys Inc / New ATHX Pharmaceutical Preparations (2834) 204864095
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1800734 Ivor Macleod 3201 Carnegie Avenue
Cleveland OH 44115-2634
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-17 15,000 $1.18 146,583 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased on the open market in multiple transactions at prices ranging from $1.16 to $1.20. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, Athersys, Inc. or a security holder of Athersys, Inc.